Generate a tailored SOP for Dr. Prakash Gupta. Improve your application with a focused, well-structured draft.
Prakash Gupta is a postdoctoral research associate in the Schizophrenia Neuropharmacology Research Group (SNRGY lab) at Yale School of Medicine. He trained in medicine at the All India Institute of Medical Sciences in New Delhi. His research explores the therapeutic potential of psychedelics for mental illness, and he currently leads a phase 1 clinical trial investigating the safety, tolerability, electrophysiological effects, and efficacy of DMT in humans. Additionally, he coordinates studies examining genetic factors that influence the response to cannabis and contribute to the vulnerability to addiction and psychosis. His work also includes investigating hippocampal synaptic vesicle density and how it relates to sustained abstinence in individuals with cannabis use disorder.
Yale School of Medicine • New Haven, CT
Conducting research in the Schizophrenia Neuropharmacology Research Group, focusing on psychedelics and cannabis response.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.